Furthermore, the mechanisms that derive this effect remain poorly characterised and therefore at this point in time, the consideration of integrating GLP1-RAs into the treatment regime for OSAHS remains in its infancy. The gene discussed is GLP1R; the disease is obstructive sleep apnea syndrome.